SEC Form 4 · accession 0001104659-18-072876
ARGAN INC · AGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William F. Leimkuhler
Director
Period of report
Dec 12, 2018
Accepted (ET)
Dec 13, 2018 · 7:25 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000100591
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 20,000 | D | ||
| Common Stock | holding | — | — | — | 1,000 | I | By Elizabeth K. Leimkuhler Trust Under Agreement dated August 30, 2005 | |
| Common Stock | holding | — | — | — | 1,000 | I | By Emily K. Leimkuhler Trust Under Agreement dated August 30, 2005 |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option to purchase Common StockF1,F2,F3 | $41.19 | Dec 12, 2019 | A | 10,000 | A | Dec 12, 2019 | Dec 12, 2028 | Common Stock | 10,000 | 70,000 | D |
Explanation of responses
- F1On December 12, 2018 (the "Grant Date"), the Reporting Person received 10-year options, vesting ratably over three years on each anniversary date from the Grant Date, to purchase 10,000 shares of the Issuer's common stock with an exercise price of $41.19 per share.
- F2The total number of stock options owned by the Reporting Person includes options to acquire (i) 10,000 shares of Common Stock at an Exercise Price of $18.87 per share with Date Exercisable of 12/18/2013 and Expiration Date of 12/18/2022; (ii) 10,000 shares of Common Stock at an Exercise Price of $26.88 per share with Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (iii) 10,000 shares of Common Stock at an Exercise Price of $31.82 per share with Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (iv) 10,000 shares of Common Stock at an Exercise Price of $30.44 per share with Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026;
- F3(v) 10,000 shares of common stock at a price of $71.75 per share with Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027; (vi) 10,000 shares of common stock at a price of $46.35 per share with Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; and (vii) 10,000 shares of common stock at a purchase price of $41.19 per share with initial Date Exercisable beginning on 12/12/2019 and Expiration Date of 12/12/2028.